Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

alt text

Register for our webinar: Meeting the Heightened Challenges of Safeguarding Health Care Providers from Needlestick Injuries with the NovaGuard® SA Pro Safety System

It’s been estimated that of the 35 million global healthcare workers that exist, 2 million of them suffer needlestick injuries each year, with approximately 500,000 of these occurring in the US. Of these, about 40% of cases go unreported each year. Due to these high numbers, regulations, laws and directives have been set to try to reduce needlestick injuries among healthcare workers. Consequently, some customers are now scrambling to understand what safety devices exist for their current and pipeline prefilled syringe (PFS) products.

In this webinar we will discuss:

  • The need for safety devices and some of the laws, directives and regulations aimed at helping to reduce needlestick injuries among healthcare workers
  • How the current COVID-19 pandemic is expected to accelerate adoption of regulations set to increase the use of safety devices to safeguard healthcare workers
  • The importance of total cost of ownership
  • Selecting a PFS safety device with manufacturer capacity
  • Safeguarding your PFS safety device supply chains through the use of more than one safety device provider
  • How the NovaGuard SA Pro safety system can deliver value to our global customers

NovaGuard® is a registered trademark of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.


alt text

Milagro Lopez

Director, Segment Marketing, Generics

West Pharmaceutical Services, Inc

Milagro E. Lopez has been a part of the biopharmaceutical industry for over 19 years. Working in a number of key support and commercial functions he has helped to create, enhance, and deliver greater value for small and large molecule products to healthcare practitioners, B2B customers, and ultimately to the patients that need them. Most recently, he joined West Pharmaceutical Services, Inc. in 2017 and, through his marketing efforts, has helped generic manufacturers gain greater understanding of the value in West’s NovaGuard® SA Pro safety device, as well as, our AccelTRA® Elastomer Components Program and how AccelTRA can help in their efforts to bring products to market quickly.

Milagro has an undergraduate in Chemistry, a Master of Science degree in Public Policy Analysis, and a Master of Business Administration from the University of Rochester and the Simon Graduate School of Business Administration, in Rochester, New York.

alt text

Rob Limouze

Director, Project Management, Devices

West Pharmaceutical Services, Inc

Rob Limouze is a product management professional with over 20 years of experience introducing and managing product lines in the medical devices and specialty chemicals markets. He obtained a BA in physics from Rutgers University and an MBA from Monmouth University. He has recently joined West Pharmaceutical Services as the Director of Product Management – Safety Devices where he is focused on expanding the safety device product line to deliver more value to West’s customers in the injectable drug market.

Moderated by

Maire Gerrard

Custom Content Writer

Informa Pharma Intelligence

Complete the form to register your place!

By completing this form you agree West Pharmaceutical Services may contact you directly about industry news, products, services and events that may be of interest to you subject to their privacy policy.